GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » EV-to-Revenue

Ebos Group (NZSE:EBO) EV-to-Revenue : 0.61 (As of May. 06, 2024)


View and export this data going back to 1960. Start your Free Trial

What is Ebos Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ebos Group's enterprise value is NZ$8,489 Mil. Ebos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NZ$13,822 Mil. Therefore, Ebos Group's EV-to-Revenue for today is 0.61.

The historical rank and industry rank for Ebos Group's EV-to-Revenue or its related term are showing as below:

NZSE:EBO' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.27   Med: 0.48   Max: 0.79
Current: 0.61

During the past 13 years, the highest EV-to-Revenue of Ebos Group was 0.79. The lowest was 0.27. And the median was 0.48.

NZSE:EBO's EV-to-Revenue is ranked worse than
51.55% of 97 companies
in the Medical Distribution industry
Industry Median: 0.6 vs NZSE:EBO: 0.61

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-06), Ebos Group's stock price is NZ$35.50. Ebos Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NZ$72.16. Therefore, Ebos Group's PS Ratio for today is 0.49.


Ebos Group EV-to-Revenue Historical Data

The historical data trend for Ebos Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group EV-to-Revenue Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.44 0.59 0.72 0.61

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.72 - 0.61 -

Competitive Comparison of Ebos Group's EV-to-Revenue

For the Medical Distribution subindustry, Ebos Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ebos Group's EV-to-Revenue falls into.



Ebos Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ebos Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8488.547/13822.477
=0.61

Ebos Group's current Enterprise Value is NZ$8,489 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NZ$13,822 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group  (NZSE:EBO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ebos Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=35.50/72.162
=0.49

Ebos Group's share price for today is NZ$35.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was NZ$72.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ebos Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (NZSE:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (NZSE:EBO) Headlines

No Headlines